Brief: Bavarian Nordic Starts Clinical Trials Of Mpox Vaccine In Infants, Pregnant Women
June 26 (Reuters) - Bavarian Nordic A/S BAVA.CO: INITIATION OF CLINICAL TRIALS OF MPOX VACCINE IN INFANTS AND PREGNANT WOMEN Source text: Link Further company coverage: BAVA.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Gets Smallpox/Mpox Vaccine Supply Contract
Brief: Bavarian Nordic Secures Additional Government Contract For The Supply Of Smallpox/Mpox Vaccine
Brief: Bavarian Nordic Launches Final Tranche Of Buy-Back Program
Bavarian Nordic falls as high costs, lower vaccine sales hit Q1 results
Bavarian Nordic Q1 revenue falls as Public Preparedness unit sales decline